Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Histone acetyltransferase p300 is a coactivator for transcription factor REL and is C-terminally truncated in the human diffuse large B-cell lymphoma cell line RC-K8.

Cancer letters | May 28, 2010

http://www.ncbi.nlm.nih.gov/pubmed/19948376

Human c-Rel (REL) is a member of the NF-kappaB family of transcription factors. REL's normal physiological role is in the regulation of B-cell proliferation and survival. The REL gene is amplified in many human B-cell lymphomas and overexpression of REL can transform chicken lymphoid cells. In this report, histone acetyltransferase p300 enhanced REL-induced transactivation and interacted with REL both in vitro and in REL-transformed chicken spleen cells and the B-lymphoma cell line RC-K8, in which REL is constitutively active and required for proliferation. However, due to a deletion in the EP300 locus, only a C-terminally truncated form of p300 is expressed in RC-K8 cells. These results suggest a role for p300 in REL-mediated oncogenic activity in B lymphoma.

Pubmed ID: 19948376 RIS Download

Mesh terms: Animals | Cell Line, Tumor | Cell Transformation, Neoplastic | Cells, Cultured | Chickens | Genes, Reporter | Glutathione Transferase | Histone Acetyltransferases | Humans | Kidney | Luciferases | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | NF-kappa B | Polymerase Chain Reaction | Proto-Oncogene Proteins c-rel | Recombinant Fusion Proteins | Transfection

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: CA047763
  • Agency: NCI NIH HHS, Id: CA047763-21S3
  • Agency: NCI NIH HHS, Id: R01 CA047763
  • Agency: NCI NIH HHS, Id: R01 CA047763-21
  • Agency: NCI NIH HHS, Id: R01 CA047763-21S1

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.